Mortality from PROWESS and ENHANCE based on end-of-infusion PC levels by categories

The protein C (PC) categories were normal (> 80%), deficient (41% to 80%), and severely deficient (< 40%). The number in each column is the total number of patients in each category. Patients were included if they had a baseline PC measure. Day 4 PC was classified as end of infusion. If day 4 measurement was not available, last observation carried forward values were used for classification. These data were reported by Vangerow and coworkers [42]. ENHANCE, Extended Evaluation of Recombinant Activated Protein C; PROWESS, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.<p><b>Copyright information:</b></p><p>Taken from "Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated)"</p><p>http://ccforum.com/content/12/2/R45</p><p>Critical Care 2008;12(2):R45-R45.</p><p>Published online 4 Apr 2008</p><p>PMCID:PMC2447591.</p><p>